Juan Caro-Codon
Overview
Explore the profile of Juan Caro-Codon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cobarro L, Jimenez-Valero S, Gutierrez-Larraya F, Merino C, Meras P, Ruiz-Cantador J, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
17:100518.
PMID: 39711775
Background: Obstructive complications in the Fontan circulation pose significant risks to affected patients. Traditional management strategies may be insufficient, necessitating innovative treatment approaches. This case report discusses the use of...
2.
Rivero-Santana B, Saldana-Garcia J, Caro-Codon J, Zamora P, Moliner P, Martinez Monzonis A, et al.
Eur Heart J
. 2024 Aug;
46(3):273-284.
PMID: 39106857
Background And Aims: Baseline cardiovascular toxicity risk stratification is critical in cardio-oncology. The Heart Failure Association (HFA) and International Cardio-Oncology Society (ICOS) score aims to assess this risk but lacks...
3.
Caro-Codon J, Munoz S, Lopez-de-Sa E
Eur Heart J
. 2022 Sep;
43(42):4519.
PMID: 36130312
No abstract available.
4.
5.
Caro-Codon J, Rey J, Iniesta A, Rosillo S, Castrejon-Castrejon S, Rodriguez-Sotelo L, et al.
Rev Port Cardiol
. 2022 Jul;
41(10):823-830.
PMID: 35784098
Background: Chronic use of Angiotensin-converting enzyme (ACE) inhibitors (ACEi) and aldosterone-receptor blockers (ARB) is not associated with worse outcomes in patients with COVID-19. However, evidence on the impact of their...
6.
Rey J, Merino Llorens J, Iniesta Manjavacas A, Rosillo Rodriguez S, Castrejon-Castrejon S, Arbas-Redondo E, et al.
Med Clin (Engl Ed)
. 2022 Jun;
158(12):586-595.
PMID: 35693916
Aims And Objectives: Statins have been proposed as potentially useful agents for modulating the host response in COVID-19. However, solid evidence-based recommendations are still lacking. Our aim was to study...
7.
Arbas-Redondo E, Rosillo-Rodriguez S, Merino-Argos C, Marco-Clement I, Rodriguez-Sotelo L, Martinez-Marin L, et al.
Rev Esp Cardiol (Engl Ed)
. 2022 May;
75(12):992-1000.
PMID: 35570124
Introduction And Objectives: Myocardial dysfunction contributes to early mortality (24-72 hours) among survivors of a cardiac arrest (CA). The benefits of mechanical support in refractory shock should be balanced against...
8.
Perone F, Aunon P, Rodriguez L, Vinal D, Caro-Codon J, Pertejo A, et al.
Monaldi Arch Chest Dis
. 2022 Feb;
92(4).
PMID: 35179011
Trastuzumab therapy has dramatically changed breast cancer prognosis. Consensus documents recommend a close monitoring during therapy, not always feasible, especially in metastatic breast cancer. The purpose of this study is...
9.
Severo Sanchez A, Rey J, Iniesta A, Merino J, Castrejon-Castrejon S, Lopez-de-Sa E, et al.
Rev Port Cardiol
. 2021 Nov;
41(4):355-357.
PMID: 34840414
No abstract available.
10.
Caro-Codon J, Rey J, Buno A, Iniesta A, Rosillo S, Castrejon-Castrejon S, et al.
Med Clin (Engl Ed)
. 2021 Sep;
157(6):274-280.
PMID: 34568576
Background: Myocardial injury has been identified as a common complication in patients with COVID-19. However, recent research has serious limitations, such as non-guideline definition of myocardial injury, heterogenicity of troponin...